Markets:

Overview

News

Currencies

International

Treasuries

Ardelyx, Inc. - Common Stock (NQ:ARDX)

5.730 -1.010 (-14.99%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Ardelyx, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Get insights into the top gainers and losers of Thursday's after-hours session. ↗

May 01, 2025

The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 01, 2025

Via Benzinga

Earnings Scheduled For May 1, 2025 ↗

May 01, 2025

Via Benzinga

Breaking Down Ardelyx: 4 Analysts Share Their Views ↗

February 21, 2025

Via Benzinga

Ardelyx Stock Rises After-Hours On Q4 Beat, Drug Sales Outlook: Retail Gets Big Dose Of Optimism ↗

February 20, 2025

Revenue for the quarter was $116.13 million, topping the consensus estimate of $111.16 million, driven by robust sales of its two approved drugs, Ibsrela and Xphozah.

Via Stocktwits

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

What Analysts Are Saying About Ardelyx Stock ↗

January 27, 2025

Via Benzinga

Beyond The Numbers: 4 Analysts Discuss Ardelyx Stock ↗

January 02, 2025

Via Benzinga

Ardelyx Beats Q3 Sales Estimates, Shares Climb ↗

October 31, 2024

Ardelyx reported its third-quarter results after Thursday's closing bell. Here's a look at the details from the report:

Via Benzinga

Ardelyx Tops Estimates as Sales Surge ↗

February 20, 2025

The biopharma reported strong revenue growth in the fourth quarter thanks to solid performances from both of its approved products, Ibsrela and Xphozah.

Via The Motley Fool

Palantir Rally Loses Steam, Walmart Outlook Disappoints: What's Driving Markets Thursday? ↗

February 20, 2025

Stocks tumbled Thursday, with all major indices in the red, one day after the S&P 500 notched another all-time high in Wednesday’s trading session.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 31, 2024

Via Benzinga

Ardelyx's Earnings Outlook ↗

October 30, 2024

Via Benzinga

What 6 Analyst Ratings Have To Say About Ardelyx ↗

August 02, 2024

Via Benzinga

Analyst Expectations For Ardelyx's Future ↗

June 20, 2024

Via Benzinga

How Is The Market Feeling About Ardelyx? ↗

June 04, 2024

Via Benzinga

Get Your Money Out of These 3 Biotech Stocks Before the End of July ↗

July 28, 2024

These stocks are at a risk of providing negative returns to shareholders due to the several operational challenges faced by the companies.

Via InvestorPlace

Ardelyx Files Lawsuit Over Medicare Drug Payment Rules, Claims It Will Limit Patient Access To Kidney Disease Treatment ↗

July 18, 2024

Ardelyx challenges CMS in a lawsuit over Medicare's inclusion of Xphozah in bundled payments, affecting kidney disease drug accessibility.

Via Benzinga

Topics Lawsuit

Why Ardelyx Stock Is Dropping ↗

July 02, 2024

Ardelyx shares are trading lower Tuesday after the company announced it has chosen not to apply to include XPHOZAH in the Centers for Medicare & Medicaid Services End-Stage Renal Disease (ESRD)...

Via Benzinga

3 Stocks Under $10 With the Potential to Make You a Millionaire ↗

June 16, 2024

Looking for volume plays? Here are three stocks under $10 that might just drive your earnings to millions in the next few years.

Via InvestorPlace

Medical Moonshots: 3 Biotech Stocks Set to Skyrocket ↗

May 30, 2024

Though risky, investors who buy biotech stocks watch their portfolios skyrocket when their drugs work as intended.

Via InvestorPlace

What Analysts Are Saying About Ardelyx Stock ↗

May 24, 2024

Via Benzinga

(ARDX) - Analyzing Ardelyx's Short Interest ↗

May 06, 2024

Via Benzinga

8 Health Care Stocks Whale Activity In Today's Session ↗

May 23, 2024

Via Benzinga

The 3 Best Penny Stocks to Buy in May 2024 ↗

May 19, 2024

Ride the momentum with these affordable penny stocks as they continue to display for solid profits this year.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

May 17, 2024

Via Benzinga

7 Cheap Penny Stocks to Buy Now: May 2024 ↗

May 15, 2024

Discover seven penny stocks poised for significant gains in 2024. Explore opportunities in cannabis, mining, EVs, and more.

Via InvestorPlace

Topics Cannabis

10 Health Care Stocks Whale Activity In Today's Session ↗

May 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 03, 2024

Via Benzinga

Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday ↗

May 03, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Ardelyx, Inc. - Common Stock (NQ:ARDX)

Headline News about Ardelyx, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today